News

WSF2021

Banner WSF2021 is an international scientific conference coordinated by the MDPI Sustainability Foundation, under the patronage of the University of Basel.

 September 2021 marks the sesquianniversary of much of the world entering into various forms of lockdown or pandemic management as well as the 6th anniversary of the 2030 Agenda for Sustainable Development and the UN Sustainable Development Goals. The pandemic has challenged our expectations for the future and has prompted a re-evaluation of the relationships between society, politics and the commercial world. In the 9th World Sustainability Forum, we will consider all aspects of these new and evolving relationships and their impact on sustainability. Although all topics are welcome, we will have major sessions on the topics of Business and Finance, Climate, Health and Medicine, Water and Education.

The 9th World Sustainability Forum will take place from 13 - 15 September 2021. For further details on how to participate, please visit https://wsf-9.sciforum.net/.

We, the chair and the organization team, are very much looking forward to welcoming you to the 9th World Sustainability Forum. Let us grab this opportunity to advance the sustainability agenda!

03.08.2021


Dear Member of the EAHL,

Nordic Permed Law is calling for abstracts for a symposium and a special edition in the European Journal of Health Law on human genome editing.

 

You can find the call below or at https://www.nordicpermedlaw.org/hot-topics/call-for-abstracts/call-for-abstracts-genome-editing-health-innovation-and-responsible-regulation

 

You are most welcome to submit an abstract, and contact the guest editors should you have any questions. Please note that the deadline is Sunday 1 August 2021. Any questions can be sent to post@nordicpermedlaw.org.

 

(signature)

CALL FOR ABSTRACTS

 

Nordic Permed Law Symposium and European Journal of Health Law (EJHL) special issue

 

Nordic Permed Law is seeking original research contributions for a symposium on genome editing on 3-4 November 2021 and a subsequent special issue on Genome Editing, Health innovation, and Responsible Regulation for EJHL.

 

This special issue will be guest-edited by Santa Slokenberga, Ana Nordberg, and Timo Minssen on behalf of Nordic Permed Law. All contributions will be subject to double-blind peer-review, a review of guest editors, and a final check by the EJHL editorial board.

 

With the recent breakthroughs in genomics and advances in gene-editing techniques, the question of genome-editing and health innovation has become particularly important in society. New techniques such as CRISPR-Cas9 hold considerable potential to enhance personalized medicine. However, their potential and possible applications also bring along complex legal and regulatory questions in the European legal environment, intersecting with ethical and social concerns. How should the law respond to genome editing and health innovation in order to adequately reconcile diverse competing interests at stake and enhance personalized medicine?

 

We welcome submissions on the European legal perspectives of genome editing in health context and impacts for personalized medicine, including but not limited to topics falling within the following domains:

-        Research regulation

-        The right to health and transformation of medical care

-        Challenges surrounding fundamental concepts in health regulation

-        Diversity and vulnerabilities

-        Governance of genome editing in both health care and dual-uses of technology

-        The management of environmental health concerns posed by gene-editing technology

-        Market structures, personal data, and intellectual property rights in genomic medicine

 

Submission Process       

We encourage submissions from both established and early-career legal scholars. Interested authors should provide an abstract of no more than 300 words in Word format and provide the following information: first name/surname, affiliation, the title of the proposed paper, and email address of the corresponding author. We kindly ask you to confirm your availability for the symposium and preference for either a presentation on site in Uppsala, Sweden (if the public health regulations allow for that) or via a digital solution.

 

Please email your abstract by 1 August 2021 to post@nordicpermedlaw.orgCandidates will be notified by 9 August 2021 about the editors’ decision. If the proposal is accepted, the draft manuscript must be circulated among the participants of the symposium by the 21 of October 2021 and the full article must be submitted by 17 December 2021.

 

Manuscripts should not exceed 9,500 words including footnotes and follow the EJHL author guidelines: https://brill.com/fileasset/downloads_products/Author_Instructions/EJHL.pdf

 

Warm wishes,

Santa Slokenberga, Ana Nordberg and Timo Minssen on behalf of the Nordic Permed Law

 

06.07.2021


HOW TO VOTE FOR OUR PROPOSAL

Using your institutional email register at: https://webgate.ec.europa.eu/hpf/

During the registration process: Use the transparency number of your institution. If your institution does not have one, type “NA” in the box.

You must select UK or an EU member state under “Country”.

The approval of your account can take a few minutes (or up to one day).

Once your account is approved, use this link https://webgate.ec.europa.eu/hpf/item/item/40200  to enter the EU Health Policy Platform and vote for our proposal.

Thank you for your support! Only three projects will be selected and will have an impact on the EU Health Policy!

Should our proposal be selected, please come back on the EU Health Policy Platform and contribute to the discussion on our proposal for the evolution and finalization of the joint statement!

The voting ends on 26 July

EAHL full proposal is available on the EC Agora voting page: EAHL_Inclusive Pharmaceutical Strategy for the EU

05.07.2021


Call for Applications – PhD Positions in “Health Law – Digitalisation and Innovation”

The Max Planck Institute for Social Law and Social Policy in Munich (MPISOC) is an interdisciplinary institute pursuing research on social questions in an international context. The Institute’s Department of Foreign and International Social Law is now offering PhD positions in “Health Law – Digitalisation and Innovation”. Potential topics include: the legal regulation of digital health devices, data protection and cybersecurity in healthcare, biomedical innovation, artificial intelligence, and personalised medicine. Comparative, transnational, and legal-historical approaches to this field are particularly welcomed. The start date is 1 September 2021, or as soon as possible thereafter.

Please send your application by 31 July 2021 to hr@mpisoc.mpg.de and leber@mpisoc.mpg.de. Your application should include a short project outline (5 pages max.), a curriculum vitae, copies of your diploma and qualifications, and (if available) a writing sample of 10-20 pages (seminar paper, journal article or book chapter).

 

For more details, visit https://www.mpisoc.mpg.de/en/career/vacancies/vacancies-details/job/phd…;

15.06.2021


Next EAHL conference - new date!

Due to the coronavirus outbreak many events around the world, including the EAHL conference, have been cancelled or postponed.

The EAHL next conference's organizers have proposed a new date, which was confirmed.

The next EAHL conference to be held on 20-22 April 2022!

Save the date!

07.05.2021


INVITATION LETTERsurvey on GDPR and eConsent

Dear,

As an important stakeholder in the field of clinical research, you are invited to take part in an online survey to share your experience on key challenges related to compliance with the EU General Data Protection Regulation (GDPR) and to obtaining informed consent prior to and during the COVID-19 pandemic.

This academic study is conducted in the context of research at KU Leuven (Belgium). It can be used to inform other projects, such as the IMI-2 consortium Corona Accelerated R&D in Europe (CARE) - a public-private partnership between academia and industry on the development of corona therapeutics. The results will support researchers in being compliant with the GDPR and in understanding the legal and ethical framework in drug development during the COVID-19 pandemic.

The survey targets: legal teams and data protection officers at research organisations and pharmaceutical companies, investigators/physicians, and ethics committees.

It consists of two parts:

  • Part 1. Compliance with the General Data Protection Regulation for clinical studies
  • Part 2. General aspects related to (electronic) informed consent

At the end of Part 1, you will be asked if you want to participate in a follow-up interview that will explore in more depth the issues related to data protection.

The study was approved by the Ethics Committee Research UZ/KU Leuven (S65106).

To participate in the survey please click on the following link: https://kuleuven.eu.qualtrics.com/jfe/form/SV_263MU2PYqS43gfY

If you know other experts who may be interested in this subject, please feel free to share the link to the survey with them.

In case of any questions or if you experience problems during the survey, you can contact Teodora Lalova (teodora.lalova@kuleuven.be or +32 2 774 16 24) or Evelien De Sutter (Evelien.desutter@kuleuven.be or +32 16 37 98 82).

Thank you very much in advance for your participation!

20.04.2021


Calling for Global Vaccine Equity
Erasmus Health Law Event

29 April 2021, 16:30 CET

The COVID-19 pandemic is a global catastrophe that has led to colossal loss of lives and livelihoods. Its impact in low-income countries is particularly severe and pre-existing inequities are further exacerbated.

Vaccination is a crucial tool in halting the pandemic. With many western countries already rolling out COVID-19 vaccines, low-income countries are largely depending on international donors such as the World Health Organization’s COVAX initiative. This joint initiative is generally considered as a global solution to realize equitable access to COVID-19 vaccines for all. Although COVAX is underway to deliver vaccines to low-income countries, so far, inequity in global access to covid-19 vaccines is causing needless deaths, and prolonging the pandemic and viral transmission that fosters variants which undermine vaccine efficacy.

On various occasions global leaders, human rights organisations and scholars remind States of their obligations under the International Covenant on Economic, Social and Cultural Rights in relation to universal access and affordability of vaccines for COVID-19, in particular in relation to international cooperation and intellectual property. They have urged States to share vaccine knowledge and expand global capacity for vaccine production.

During this seminar several speakers will respond to the plea for a more equitable distribution of COVID-19 vaccines.

Speakers
- Dr. Ellen ‘t Hoen, researcher at the University Medical Centre at the University of Groningen
(The Netherlands).
- Dr Yuan Hu, Senior Legal & Policy Advisor Médecins Sans Frontières (Geneva)
- Isabel de la Mata Barranco, Principal Advisor for Health and Crisis Management, European Commission
- Prof. dr. Ole Norheim (Bergen University, department Global Health Ethics)
The event is hosted by Erasmus School of Law, Health Law Group

Free access (Zoom): https://eur-nl.zoom.us/j/93616371111

Contact: denexter@law.eur.nl

09.04.2021


Update

The webinar on vaccination passports in the form of “digital green certificates” in order to facilitate the safe free movement of citizens of one Member State to and in other EU Member States has been held successfully.

The presentations can be found on our website at https://eahl.eu/reports/webinar-covid

28.03.2021


The European Commission has launched its plan to introduce vaccination passports in the form of “digital green certificates” in order to facilitate the safe free movement of citizens of one Member State to and in other EU Member States. The certificate will serve as a digital proof that a person has been vaccinated against COVID-19, has recovered from COVID-19 or has a negative test result. The introduction of these vaccination passports poses many questions, specially with regard to the necessary legal framework and its legal consequences. The European Association of Health Law has therefore taken the initiative to organize a free webinar on COVID-19 and vaccination passports. During this webinar several health lawyers will give their expert opinion on this topic during brief presentations and a closing debate.

Speakers include:

Tom Goffin, Judit Sandor, André den Exter, Maria Sharkova and Mahsa Shabani

The webinar will be held on Zoom Thursday 25 March at 5:30 (Central European Time).

https://uib.zoom.us/j/63153732351?pwd=S0RJNGFzSk1RaXVRREIrRkNpYmFrUT09

Passcode: K9tpt53r

19.03.2021


The Max Planck Institute for Social Law and Social Policy in Munich is an interdisciplinary research institute engaging with a broad range of topics in the field of foreign and international social law. Our Institute is now offering several PhD positions in “Digital Health – Digitalisation in Health Law”. Possible topics include data protection and cybersecurity in healthcare, personalised medicine, and legal regulation of digital health.

Candidates should have knowledge in digital law and/or international comparative law, as well as good language skills in English and German. Please send your application until March 15th, 2021 to hr@mpisoc.mpg.de and leber@mpisoc.mpg.de. Your application should include a CV, a list of publications, a short project outline (5 pages max.), and copies of your certificates/qualifications.

For more details, please, click here.

02.02.2021


All news of 2020

 


New medical law books - discounts for EAHL members! Details herehttps://eahl.eu/recent-publications

Please, visit https://eahl.eu/earlier-news page to access earlier news that was shared by the EAHL.